{
    "clinical_study": {
        "@rank": "36800", 
        "acronym": "PETU", 
        "arm_group": [
            {
                "arm_group_label": "Staphylococcus aureus bacteremia", 
                "description": "PET/CT in patients with Staphylococcus aureus bacteremia"
            }, 
            {
                "arm_group_label": "Salmonella spp. bacteremia", 
                "description": "PET/CT in patients with Salmonella spp. bacteremia"
            }, 
            {
                "arm_group_label": "Endocarditis", 
                "description": "PET/CT in patients with infective endocarditis"
            }, 
            {
                "arm_group_label": "Pacemaker infection", 
                "description": "PET/CT in patients with pacemaker infection"
            }, 
            {
                "arm_group_label": "Vasculitis", 
                "description": "PET/CT in patients with vasculitis"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the value of positron emission tomography/computed\n      tomography in various inflammatory conditions caused by bacterial infection or vasculitis.\n      Glucose analog FDG is sensitive to detect inflammation foci but we hypothesize that other\n      imaging agents such as PK11195 and Ga-citrate may have added value in certain applications."
        }, 
        "brief_title": "Positron Emission Tomography of Infection and Vasculitis", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Infection", 
            "Vasculitis"
        ], 
        "condition_browse": {
            "mesh_term": "Vasculitis"
        }, 
        "detailed_description": {
            "textblock": "The purpose of this study is to evaluate the value of PET/CT in various inflammatory\n      conditions caused by bacterial infection or vasculitis. Our aim is to:\n\n        1. investigate whether FDG (18F-2-fluoro-2-deoxy-D-glucose fluorodeoxyglucose) PET/CT and\n           68Ga-(Gallium-68) citrate PET/CT enable the early and accurate detection of metastatic\n           infection foci in Staphylococcus aureus bacteremia.\n\n        2. study the usefulness of FDG PET/CT in detection of endovascular infection in bacteremia\n           caused by Salmonella spp.\n\n        3. find an optimal FDG PET/CT protocol for detection of infectious endocarditis and\n           metastatic infection foci related to endocarditis.\n\n        4. study the value of  FDG PET/CT in the diagnosis of infection of pacemaker or\n           implantable cardioverter defibrillator.\n\n        5. investigate the usefulness of FDG PET/CT, 68Ga-citrate PET/CT, and 11C- (carbon-11)\n           translocator protein ligand (PK11195) PET/CT in diagnosis of vasculitis and in imaging\n           of the magnitude of the vascular changes."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        Adults with\n\n          -  Staphylococcus aureus bacteremia or\n\n          -  Salmonella spp. bacteremia or\n\n          -  infective endocarditis or\n\n          -  infection of pacemaker or implantable cardioverter defibrillator or\n\n          -  vasculitis\n\n        Exclusion Criteria:\n\n          -  underage, pregnant, breastfeeding, handicapped or prisoner"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients of Turku University Hospital"
            }
        }, 
        "enrollment": {
            "#text": "117", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 10, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01878721", 
            "org_study_id": "14824"
        }, 
        "intervention": {
            "arm_group_label": [
                "Staphylococcus aureus bacteremia", 
                "Salmonella spp. bacteremia", 
                "Endocarditis", 
                "Pacemaker infection", 
                "Vasculitis"
            ], 
            "description": "positron emission tomography/computed tomography", 
            "intervention_name": "PET/CT", 
            "intervention_type": "Radiation"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "PET/CT", 
            "infection", 
            "vasculitis"
        ], 
        "lastchanged_date": "June 14, 2013", 
        "location": {
            "contact": {
                "email": "ulla.hohenthal@tyks.fi", 
                "last_name": "Ulla Hohenthal, MD, PhD"
            }, 
            "contact_backup": {
                "email": "laura.pirila@tyks.fi", 
                "last_name": "Laura Piril\u00e4, MD, PhD"
            }, 
            "facility": {
                "address": {
                    "city": "Turku", 
                    "country": "Finland", 
                    "zip": "FI-20521"
                }, 
                "name": "Turku University Hospital"
            }, 
            "investigator": {
                "last_name": "Anne Roivainen, PhD", 
                "role": "Sub-Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Finland"
        }, 
        "number_of_groups": "5", 
        "official_title": "Positron Emission Tomography of Infection and Vasculitis (PETU)", 
        "overall_contact": {
            "email": "ulla.hohenthal@tyks.fi", 
            "last_name": "Ulla Hohenthal, MD, PhD"
        }, 
        "overall_contact_backup": {
            "email": "laura.pirila@tyks.fi", 
            "last_name": "Laura Piril\u00e4, MD, PhD"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Finland: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Detection of infection or vasculitis in PET images", 
            "safety_issue": "No", 
            "time_frame": "within 1 week after starting the treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01878721"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Turku University Hospital", 
            "investigator_full_name": "Anne Roivainen", 
            "investigator_title": "professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Standardized uptake value of PET imaging agent at the site of infection or vasculitis", 
            "safety_issue": "No", 
            "time_frame": "within 1 week after starting the treatment"
        }, 
        "source": "Turku University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Turku University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2011", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "June 2013"
    }
}